Rilpivirine combination product in pretreated HIV-1 patients: Added benefit not proven
Monday, April 7, 2014 - 15:01
in Health & Medicine
A Rilpivirine combination product in HIV-1 patients with previous antiretroviral treatment was not shown to demonstrate any added benefit in a recent study. The only study cited in the dossier was too short for the assessment of an added benefit, and the appropriate comparator therapy was not implemented.